Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2140914
下载链接
链接失效反馈官方服务：
资源简介：
The aim of this study is to investigate the following schedules for efficacy with regard to response rate in neoadjuvant treatment of patients with non-resectable liver metastases:
* Cetuximab/FOLFOXIRI and cetuximab/FOLFIRI in patients with ras wild type tumours and
* Bevacizumab/FOLFOXIRI and FOLFOXIRI in patients with ras mutant tumours.
创建时间：
2013-03-15
